AGL-2043

CN1C(C)=NC2=C1C=C3N=CC(=NC3=C2)C4=CC=CS4

InChIKey=ZGDACLBJJXLKJY-UHFFFAOYSA-N

InChI=1S/C15H12N4S/c1-9-17-12-6-11-10(7-14(12)19(9)2)16-8-13(18-11)15-4-3-5-20-15/h3-8H,1-2H3

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

PubMed

Title	Date	PubMed
Tricyclic quinoxalines as potent kinase inhibitors of PDGFR kinase, Flt3 and Kit.	2003 May 1	12670652
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.	2013 Apr 15	23398362

Substance Class	Chemical Created by `admin` on `Sat Dec 16 09:00:28 GMT 2023` Edited by `admin` on `Sat Dec 16 09:00:28 GMT 2023`
Record UNII	8OO2SLF34L
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

AGL-2043

Common Name

English

1H-IMIDAZO(4,5-G)QUINOXALINE, 1,2-DIMETHYL-6-(2-THIENYL)-

Systematic Name

English

Code System Code Type Description

FDA UNII

8OO2SLF34L

Created by admin on Sat Dec 16 09:00:28 GMT 2023 , Edited by admin on Sat Dec 16 09:00:28 GMT 2023

PRIMARY

CAS

226717-28-8

Created by admin on Sat Dec 16 09:00:28 GMT 2023 , Edited by admin on Sat Dec 16 09:00:28 GMT 2023

PRIMARY

PUBCHEM

9817165

Created by admin on Sat Dec 16 09:00:28 GMT 2023 , Edited by admin on Sat Dec 16 09:00:28 GMT 2023

PRIMARY

Related Record Type Details


					8OO2SLF34L

AGL-2043

ACTIVE MOIETY